Claman on Call: Ebola Makers Race to Find a Cure

Chinese government still not giving in to Hong Kong protesters' demands

Claman on Call: FBN's Liz Claman with an after-hours web exclusive on the markets, Ebola and the protests in Hong Kong.

Investors saw a major market selloff on Wednesday -- all three major indices had their biggest drop since Sept. 25.

Continue Reading Below

And taking a look at the Russell 2000, the small cap index officially entered correction territory, down 10% from its highs. Dan Wantrobski, Janney Capital Markets director of technical research, joined FOX Business and says the index would have to rise to 1225 for a bullish breakout.

Part of the reason the market was so volatile today is that the first case of Ebola was diagnosed on U.S. soil in Dallas on Tuesday. Chris Garabedia, CEO of Sarepta, also joined FOX Business and said his company has been testing a possible Ebola cure in monkeys. Garabedian told us while has been in constant contact with the CDC and FDA, as of right now they have not asked him to deploy his drug. However, he is willing to help in any way possible. Head to for his full interview.

And thousands more have joined the peaceful protests in Hong Kong on China's National Day. The Chinese government has not given into any of the protest demands, but the White House has issued a statement in support of the demonstrators. Secretary of State John Kerry met with Chinese Foreign Minister Wang Yi to discuss the president's upcoming trip to China, and according to sources, the protests were on the agenda.

Now, here is what you need to watch for tomorrow: At 8:30 a.m. ET, jobless claims data come out ... one day before Friday's big jobs report. And at 10 a.m. ET, factory orders are released. FOX Business will also be watching a speech by President Obama on the economy due to start at 2:15 p.m. ET. 

Be sure to check out all of today's interviews on and tune into Countdown to the Closing Bell every week day at 3 p.m. ET.

What do you think?

Click the button below to comment on this article.